A heritage of over 29 years working with a singular objective of improving the quality of patients' lives worldwide, through expanded access to advanced medications.

Masters Speciality Pharma is a leading international pharmaceutical company with expertise in responding to the unmet needs and preferences of patients and healthcare professionals. Masters specialise in supplying advanced medicines to Hospitals, Pharmacists, Clinics and Governments as well as directly to individual patients, in over 90 countries worldwide.

Established in 1984, Masters is principally engaged in the compliant sourcing of a broad range of established branded prescription drugs (or their generic equivalent) and pharmacy medicines.

Other activities include the legal importation of innovative life-saving licensed medicines commonly available in the USA and Europe, which are typically difficult to access from outside these markets to countries where market authorisation has not been obtained.

Our expertise covers key strategic areas such as:-

  • Procurement service for Private Clinics, Hospitals, Government Institutions and Retail Pharmacies.
  • Home Office Controlled Drugs Licensed to store and distribute Controlled Drugs.
  • Named Patient Supply (NPS), Expanded Access Program (EAP) - the early access to unlicensed medicines and also orphan drugs for rare diseases to named patients.
  • Exclusive distribution agreements, fostering and in-licensing of late-stage and commercialised pharmaceuticals.
  • Market Authorisation or acquisition/product ownership.
  • Personal Importation of prescription drugs to individual patients.




Wednesday 18 January 2017

Masters Speciality Pharma is pleased to announce its appointment as Amgen (Europe) GmbH’s exclusive supplier.

Find out more